Stryker Corporation (SYK)

SYK (NYSE:Health Services) EQUITY
$96.44
pos +0.00
+0.00%
Today's Range: 95.79 - 96.71 | SYK Avg Daily Volume: 1,280,300
Last Update: 05/22/15 - 4:03 PM EDT
Volume: 0
YTD Performance: 2.24%
Open: $0.00
Previous Close: $96.40
52 Week Range: $77.87 - $98.24
Oustanding Shares: 378,409,144
Market Cap: 36,478,641,482
6-Month Chart
TheStreet Ratings Grade for SYK
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 13 12 12 11
Moderate Buy 2 2 2 2
Hold 5 5 6 7
Moderate Sell 0 0 0 0
Strong Sell 1 1 0 0
Mean Rec. 1.74 1.77 1.67 1.77
Latest Dividend: 0.34
Latest Dividend Yield: 1.43%
Dividend Ex-Date: 06/26/15
Price Earnings Ratio: 55.40
Price Earnings Comparisons:
SYK Sector Avg. S&P 500
55.40 55.20 27.11
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
1.25% 19.67% 86.47%
GROWTH 12 Mo 3 Yr CAGR
Revenue 7.20 0.16 0.05
Net Income -48.80 -0.62 -0.27
EPS -48.90 -0.61 -0.27
Earnings for SYK:
EBITDA 1.62B
Revenue 9.68B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $1.17 $1.20 $5.03 $5.53
Number of Analysts 13 13 19 19
High Estimate $1.18 $1.23 $5.15 $5.87
Low Estimate $1.15 $1.17 $5.00 $5.39
Prior Year $1.08 $1.15 $4.73 $5.03
Growth Rate (Year over Year) 7.91% 4.01% 6.43% 9.81%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

David Katz

 | May 20, 2015 | 8:00 AM EDT

It's time to take some profits on the company's success.

bearishStryker estimates, target reduced at Leerink

Jan 28, 2015 | 8:05 AM EST

Shares of SYK now seen reaching $103, according to Leerink Partners. Estimates also cut, given the company's currency exposure. Outperform rating. 

bearishStryker downgraded at JP Morgan

Jan 5, 2015 | 7:55 AM EST

SYK was downgraded from Overweight to Neutral, JP Morgan said. $94 price target. Valuation call, as the stock is up more than 71% over the past two years. 

By

Jim Cramer

 | Dec 22, 2014 | 7:00 AM EST

Throughout this historic run, four groups have consistently led the market.

By

Jim Cramer

 | Dec 15, 2014 | 7:08 AM EST

Reams of stocks make sense on a pullback. And what looks bad? Anything even remotely connected to oil and gas.

bullishStryker added to Conviction Buy List at Goldman

Dec 2, 2014 | 7:24 AM EST

SYK was placed on the Conviction Buy list, according to Goldman Sachs. $108 price target. Company has a strong balance sheet and should benefit from improving hospital spending. 

By

Doug Kass

 | Sep 17, 2014 | 8:50 AM EDT
Where it began.

updateSYK Analyst Mtg.

Sep 17, 2014 | 7:39 AM EDT

SYK - Stryker Corp Analyst Meeting - 2:30PM

By

Doug Kass

 | Jul 17, 2014 | 7:28 AM EDT
Where it began.

bullishStryker upgraded at Argus

Jun 11, 2014 | 8:17 AM EDT

SYK was upgraded from Hold to Buy, Argus Research said. $102 price target. Company is generating solid growth outside of orthopedics. 

 

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.